about
Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrateThe mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations.Several transport systems contribute to the intestinal uptake of Paraquat, modulating its cytotoxic effects.Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.RBE4 cells are highly resistant to paraquat-induced cytotoxicity: studies on uptake and efflux mechanisms.Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event.Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells.P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging.Interaction of polyacrylic acid coated and non-coated iron oxide nanoparticles with human neutrophils.Combining CXCR4-targeted and nontargeted nanoparticles for effective unassisted in vitro magnetic hyperthermia.Performance enhanced UV/vis spectroscopic microfluidic sensor for ascorbic acid quantification in human blood.Green synthesis of fluorescent carbon dots from spices for in vitro imaging and tumour cell growth inhibition.Primary hepatocytes and their cultures for the testing of drug-induced liver injuryMechanisms and in vitro models of drug-induced cholestasisIndustrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis
P50
Q28535627-6471644C-72A5-481A-A333-9E0108E18BCCQ34375859-06E65D6D-7A21-4703-A54C-AF284902999AQ35470890-BD457556-577D-443D-875F-CBF033DE74C3Q38272833-B86521BE-F8E9-4D9E-9B6C-BAE27B76B937Q39084328-A1D1ED07-D114-4D3D-AD0A-D3A00B9A9FC1Q39094453-153225E0-F0D5-4644-B006-B91F135EBF42Q39150259-F39722CB-D9C6-43F8-A2F7-00CFCA004F48Q42726170-977C3248-8EC7-42E2-BD76-5A4D3BD83873Q45344545-BFC3D55C-E715-4C82-BC39-BF0865109708Q45983207-4B19556D-95D1-49F2-911A-CAA4067392D6Q50062317-6D671956-8C5D-4B85-8C78-C64B5234709BQ50848513-D70FB959-859E-4A93-86A4-F2C6F346898FQ54938965-6E28C3B9-4CF6-4D43-B869-370103E12D74Q91896615-EDF03EA4-05D9-4D84-AF0A-CA9DF112DC4BQ93016108-74863C6F-0D2D-43D4-8497-A7895014081DQ93057382-F2C75D25-C178-4205-A41D-FF727C8DA6C9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vânia Vilas-Boas
@ast
Vânia Vilas-Boas
@en
Vânia Vilas-Boas
@es
Vânia Vilas-Boas
@nl
type
label
Vânia Vilas-Boas
@ast
Vânia Vilas-Boas
@en
Vânia Vilas-Boas
@es
Vânia Vilas-Boas
@nl
prefLabel
Vânia Vilas-Boas
@ast
Vânia Vilas-Boas
@en
Vânia Vilas-Boas
@es
Vânia Vilas-Boas
@nl
P106
P1153
49864811400
P21
P31
P496
0000-0002-4798-2158